Cargando…

International external validation of a stratification tool to identify branch‐duct intraductal papillary mucinous neoplasms at lowest risk of progression

BACKGROUND: Identifying branch‐duct intraductal papillary mucinous neoplasms (BD‐IPMNs) at lowest risk of progression may allow for a reduced intensity of surveillance. OBJECTIVE: We aimed to externally validate the previously developed Dutch‐American Risk stratification Tool (DART‐1; https://rtools...

Descripción completa

Detalles Bibliográficos
Autores principales:	Overbeek, Kasper A., van Leeuwen, Nikki, Tacelli, Matteo, Anwar, Muhammad S., Yousaf, Muhammad N., Chhoda, Ankit, Arcidiacono, Paolo Giorgio, Gonda, Tamas A., Wallace, Michael B., Capurso, Gabriele, Farrell, James J., Cahen, Djuna L., Bruno, Marco J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Hepatobiliary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911544/ https://www.ncbi.nlm.nih.gov/pubmed/35199484 http://dx.doi.org/10.1002/ueg2.12207

Ejemplares similares

Development of a stratification tool to identify pancreatic intraductal papillary mucinous neoplasms at lowest risk of progression
por: Overbeek, Kasper A., et al.
Publicado: (2019)

Risk stratification tools for branch‐duct intraductal papillary mucinous neoplasms of the pancreas
por: Balduzzi, Alberto, et al.
Publicado: (2022)

Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms
por: Chhoda, Ankit, et al.
Publicado: (2023)

Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
por: Pozzi Mucelli, Raffaella M., et al.
Publicado: (2022)

Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0
por: Zanetto, Alberto, et al.
Publicado: (2023)

Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022)

Management of Intraductal Papillary Mucinous Neoplasms: Controversies in Guidelines and Future Perspectives
por: Levink, IJM, et al.
Publicado: (2018)

Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms
por: Capurso, Gabriele, et al.
Publicado: (2020)

TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma
por: Lima, Henrique A., et al.
Publicado: (2022)

The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy
por: Pereyra, D., et al.
Publicado: (2019)

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
por: Saha, Supriya K., et al.
Publicado: (2016)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma
por: Sanoff, Hanna K., et al.
Publicado: (2016)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges
por: Liu, Xiufeng, et al.
Publicado: (2019)

Nivolumab in Advanced Hepatocellular Carcinoma: Safety Profile and Select Treatment‐Related Adverse Events From the CheckMate 040 Study
por: Julien, Karen, et al.
Publicado: (2020)

Correlation of liver-to-spleen ratio, lung CT scores, clinical, and laboratory findings of COVID-19 patients with two consecutive CT scans
por: Guler, Ezgi, et al.
Publicado: (2020)

Feasibility and safety of bedside percutaneous biliary drainage in patients with severe cholangitis
por: Gupta, Pankaj, et al.
Publicado: (2020)

Higher frequency of hepatic steatosis at CT among COVID-19-positive patients
por: Medeiros, Augusto Kreling, et al.
Publicado: (2020)

CT of amebic liver abscess: different morphological types with different clinical features
por: Priyadarshi, Rajeev Nayan, et al.
Publicado: (2021)

The natural course of giant paraesophageal hernia and long-term outcomes following conservative management
por: Oude Nijhuis, Renske A B, et al.
Publicado: (2020)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Inhibition of NAE‐dependent protein hyper‐NEDDylation in cystic cholangiocytes halts cystogenesis in experimental models of polycystic liver disease
por: Lee‐Law, Pui Y., et al.
Publicado: (2021)

Neoadjuvant Treatment with Angiogenesis‐Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II Study
por: Woei‐A‐Jin, F.J. Sherida H., et al.
Publicado: (2021)

Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics
por: Silva, Mario, et al.
Publicado: (2021)

Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort
por: Llop, Elba, et al.
Publicado: (2021)

Real-time virtual sonography-assisted radiofrequency ablation in liver tumors with conspicuous or inconspicuous images or peritumoral landmarks under ultrasonography
por: Huang, Hsin-Chih, et al.
Publicado: (2021)

Portosystemic shunt surgery in the era of TIPS: imaging-based planning of the surgical approach
por: Fehrenbach, Uli, et al.
Publicado: (2020)

CT angiography of abdomen and pelvis in critically ill COVID-19 patients: imaging findings and correlation with the CT chest score
por: Vadvala, Harshna V., et al.
Publicado: (2021)

Spectrum of Fontan-associated liver disease assessed by MRI and US in young adolescents
por: Thrane, Karl Julius, et al.
Publicado: (2021)

Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2
por: Jiang, Hao, et al.
Publicado: (2021)

Epidemiology of pyogenic liver abscesses in Germany: Analysis of incidence, risk factors and mortality rate based on routine data from statutory health insurance
por: Zimmermann, Lisa, et al.
Publicado: (2021)

Reproducibility of liver R2* quantification for liver iron quantification from cardiac R2* acquisitions
por: Muehler, M. R., et al.
Publicado: (2021)

Repeatability and reproducibility of deep-learning-based liver volume and Couinaud segment volume measurement tool
por: Mojtahed, Amirkasra, et al.
Publicado: (2021)

Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Müller, Lukas, et al.
Publicado: (2021)

Clinical management of chronic hepatitis B: A concise overview
por: Furquim d’Almeida, Arno, et al.
Publicado: (2021)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

A new proposal for secondary surveillance following potentially curative therapy of HCC: alternating MRI and CEUS
por: Bansal, Sanjay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nj7v7maod4n9o4edtpvcg1faea